Dovitinib (TKI-258) Dilactic Acid
Modify Date: 2024-01-03 17:07:59
Dovitinib (TKI-258) Dilactic Acid structure
|
Common Name | Dovitinib (TKI-258) Dilactic Acid | ||
|---|---|---|---|---|
| CAS Number | 852433-84-2 | Molecular Weight | 572.59 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H33FN6O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Dovitinib (TKI-258) Dilactic AcidDovitinib (dilactic acid) is an orally active inhibitor of VEGF kinase. Dovitinib (dilactic acid) inhibits receptor tyrosine kinases (RTKs) involved in solid and hematologic cancers and tumor angiogenesis[1]. |
| Name | 2-Hydroxypropanoic acid-4-amino-5-fluoro-3-[5-(4-methyl-1-piper azinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone (2:1) |
|---|---|
| Synonym | More Synonyms |
| Description | Dovitinib (dilactic acid) is an orally active inhibitor of VEGF kinase. Dovitinib (dilactic acid) inhibits receptor tyrosine kinases (RTKs) involved in solid and hematologic cancers and tumor angiogenesis[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C27H33FN6O7 |
|---|---|
| Molecular Weight | 572.59 |
| Exact Mass | 572.239502 |
| PSA | 209.36000 |
| LogP | 2.44450 |
| Storage condition | -20℃ |
| Dovitinib (TKI-258) Dilactic Acid |
| Propanoic acid, 2-hydroxy-, compd. with 4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone (2:1) |
| Dovitinib Dilactic acid |
| 2-Hydroxypropanoic acid - 4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone (2:1) |
| TKI258 Dilactic acid |
| Dovitinib Dilacticacid |